Patent details

Basic Information

Publication number:

EP2178916

PCT Application Number:

PCT/US/2008/071709

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087969176

PCT Publication Number:

WO/2009/018411

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HUMAN ANTIBODIES TO HUMAN CD20 AND METHOD OF USING THEREOF

French Title of Invention:

ANTICORPS HUMAINS CONTRE LE CD20 HUMAIN ET LEUR PROCEDE D'UTILISATION

German Title of Invention:

MENSCHLICHE ANTIKÖRPER GEGEN HUMANES CD20 UND VERFAHREN ZU IHRER ANWENDUNG

SPC Number:

Dates

Filing date:

31/07/2008

Grant date:

17/12/2014

EP Publication Date:

17/12/2014

PCT Publication Date:

05/02/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/04/2010

EP B1 Publication Date:

17/12/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/07/2015

Expiration date:

31/07/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/07/2008

 

 

Name:

Regeneron Pharmaceuticals Inc.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Inventor

1

Name:

WANG Li-Hsien

Address:

United States (US)

2

Name:

MARTIN Joel, H.

Address:

United States (US)

3

Name:

ALLISON Erin, M.

Address:

United States (US)

4

Name:

STEVENS Sean

Address:

United States (US)

Priority

1

Priority Number:

962811 P

Priority Date:

31/07/2007

Priority Country:

United States (US)

2

Priority Number:

67994 P

Priority Date:

03/03/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 16/28;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages